Morgan Stanley’s Heliogen, Inc. HLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-112,189
Closed -$424K 8010
2023
Q3
$424K Buy
112,189
+79,620
+244% +$579K ﹤0.01% 5241
2023
Q2
$279K Buy
32,569
+13,357
+70% +$122K ﹤0.01% 5495
2023
Q1
$162K Sell
19,212
-9,678
-33% -$147K ﹤0.01% 5804
2022
Q4
$706K Sell
28,890
-146,303
-84% -$6.6M ﹤0.01% 5057
2022
Q3
$11.4M Sell
175,193
-795
-0.5% -$62K ﹤0.01% 2805
2022
Q2
$13M Sell
175,988
-9,097
-5% -$1.18M ﹤0.01% 2780
2022
Q1
$34.1M Buy
185,085
+6,350
+4% +$1.16M ﹤0.01% 1583
2021
Q4
$97.1M Buy
178,735
+178,716
+940,611% +$62.6M 0.01% 917
2021
Q3
$7K Buy
+19
New +$6.58K ﹤0.01% 7427

Other funds holding HLGN

Morgan Stanley's HLGN Position: Q4 2023 in Review

Morgan Stanley sold out of Heliogen, Inc. (HLGN) in Q4 2023, closing a stake of 112,189 shares — an estimated $424K sold.

Morgan Stanley first reported a position in HLGN in Q3 2021 and held it in 9 quarters. The position peaked at $97.1M in Q4 2021. 5 funds tracked by Wall St. Rank hold HLGN as of Q4 2023.

  • Morgan Stanley reported no remaining Heliogen, Inc. position as of Q4 2023 after selling out during the quarter.
  • Morgan Stanley sold 112,189 Heliogen, Inc. shares in Q4 2023, an estimated $424K.
  • Morgan Stanley first reported a position in Heliogen, Inc. in Q3 2021 and held it in 9 quarters.
  • Morgan Stanley's Heliogen, Inc. position peaked at $97.1M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.